Literature DB >> 1396730

Monitoring of antibiotic resistance in shigellae isolated in The Netherlands 1984-1989.

C E Voogd1, C S Schot, W J van Leeuwen, B van Klingeren.   

Abstract

During surveillance of antimicrobial resistance in Shigella strains isolated in the Netherlands from 1984 to 1989 and forwarded to the National Institute of Public Health and Environmental Protection for typing, sensitivity to twelve antimicrobial agents was assessed. High rates of resistance to the older drugs of choice in treating shigellosis were found, i.e. ampicillin and trimethoprim-sulfamethoxazole. Ampicillin resistance varied from 33 to 53% among Shigella flexneri strains and from 10 to 17% among Shigella sonnei strains. Trimethoprim and trimethoprim-sulfamethoxazole resistance increased from 8% to about 25% among Shigella flexneri and from 16 to 46% among Shigella sonnei isolates. All strains were susceptible to the newer quinolones, but five strains resistant to nalidixic acid showed decreased susceptibility to norfloxacin. Approximately 10% of the isolates were resistant to the combination of ampicillin, trimethoprim and sulfamethoxazole.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396730     DOI: 10.1007/bf01967070

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  High-level resistance to trimethoprim in Shigella sonnei associated with plasmid-encoded dihydrofolate reductase type I.

Authors:  R Delgado; J R Otero
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

2.  Transferable or mobilisable antibiotic resistance in Shigella dysenteriae types 1, 2, 3, 4, 6 and 7 isolated in Ethiopia during 1974-85.

Authors:  A Gebre-Yohannes; B S Drasar
Journal:  J Med Microbiol       Date:  1988-12       Impact factor: 2.472

3.  [Antibiotic resistance in the isolates of Shigella flexneri type 2 associated with the "shrimp epidemic"].

Authors:  B van Klingeren; W J van Leeuwen; M E Heck; C E Voogd
Journal:  Ned Tijdschr Geneeskd       Date:  1985-05-11

4.  Plasmid-mediated drug resistance of shigellae in Kuwait.

Authors:  T D Chugh; A Suheir; A G Mahboob; L Neil; E el-Bishbishi
Journal:  Antonie Van Leeuwenhoek       Date:  1985       Impact factor: 2.271

5.  Resistant Shigella dysenteriae.

Authors:  B R Panhotra; B Desai
Journal:  Lancet       Date:  1983-12-17       Impact factor: 79.321

6.  Susceptibilities of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and new 4-quinolones.

Authors:  J Ling; K M Kam; A W Lam; G L French
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

7.  Serotype prevalence and antibiotic susceptibility of Shigella strains isolated in Malaysia during 1980 and 1981.

Authors:  M Jegathesan
Journal:  J Diarrhoeal Dis Res       Date:  1984-06

8.  [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].

Authors:  I Habiyaremye; L Verbist; J Vandepitte
Journal:  Pathol Biol (Paris)       Date:  1987-06

9.  Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin.

Authors:  M L Bennish; M A Salam; R Haider; M Barza
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

10.  Introduction and spread of multi-resistant Shigella dysenteriae I in Thailand.

Authors:  D N Taylor; L Bodhidatta; J E Brown; P Echeverria; C Kunanusont; P Naigowit; S Hanchalay; A Chatkaeomorakot; A A Lindberg
Journal:  Am J Trop Med Hyg       Date:  1989-01       Impact factor: 2.345

View more
  11 in total

1.  Hydrophobicity and outer membrane proteins of Shigella dysenteriae type 1 after treatment with subinhibitory concentrations of aminoglycosides.

Authors:  A Hostacká; E Karelová
Journal:  Folia Microbiol (Praha)       Date:  1997       Impact factor: 2.099

Review 2.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

3.  Increased resistance of enteropathogens to fluoroquinolones in Barcelona, Spain.

Authors:  F Navarro; E Miró; C Izquierdo; B Mirelis; G Prats
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

4.  Marked decrease in susceptibility of Shigella to ampicillin and cotrimoxazole in Israel.

Authors:  M Dan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

5.  Bacterial pathogens associated with diarrhoea on the island of Crete.

Authors:  G Samonis; S Maraki; A Christidou; A Georgiladakis; Y Tselentis
Journal:  Eur J Epidemiol       Date:  1997-10       Impact factor: 8.082

6.  Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995.

Authors:  Y W Chu; E T Houang; D J Lyon; J M Ling; T K Ng; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 7.  The epidemiology of bacterial resistance to quinolones.

Authors:  J F Acar; T F O'Brien; F W Goldstein; R N Jones
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993.

Authors:  A A Lima; N L Lima; M C Pinho; E A Barros Juñior; M J Teixeira; M C Martins; R L Guerrant
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 9.  Epidemiology of quinolone resistance: Europe and North and South America.

Authors:  F W Goldstein; J F Acar
Journal:  Drugs       Date:  1995       Impact factor: 9.546

10.  Epidemiology of Shigella infections in two ethnic groups in a geographic region in southern Israel.

Authors:  Y Finkelman; P Yagupsky; D Fraser; R Dagan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.